Mechanism: Reduction in receptor mediated clearance of LDL Due to mutation of LDLR, APOB or PCSK9 gene. Prevalence: 1 in 250. Lipid Profile: Elevated LDL-cholesterol, TC 9-12mmol/L, Low normal fasting triglycerides. Inheritance: Autosomal co-dominant. Physical Signs: Tendon Xanthomas, corneal arcus. Homozygotes – also planar digital and natal cleft cutaneous xanthomas, aortic stenosis. CHD risk: Very high (symptomatic in 50% of males by age 50, 50% of females by age 60)